Last10K.com

Cme Group Inc. (CME) SEC Filing 10-Q Quarterly report for the period ending Monday, September 30, 2019

Cme Group Inc.

CIK: 1156375 Ticker: CME






Exhibit 99.1
 
cmegpressrelease1a01a19.jpg
 
 
Media contact
Investor contact
 
Anita Liskey, 312.466.4613
John Peschier, 312.930.8491
 
Chris Grams, 312.930.3435
CME-G
 
news@cmegroup.com
 
 
www.cmegroup.mediaroom.com
 

FOR IMMEDIATE RELEASE

CME Group Inc. Reports Third-Quarter 2019 Financial Results

CHICAGO, October 30, 2019 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2019.
The company reported revenue of $1.3 billion and operating income of $685 million for the third quarter of 2019. Net income was $636 million and diluted earnings per share were $1.78. On an adjusted basis, net income was $679 million and diluted earnings per share were $1.90. Financial results presented on an adjusted basis for the third quarter of 2019 and 2018 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1 

"Clients continued to turn to CME Group markets to manage their risk during this period of increased volatility and geopolitical uncertainty," said CME Group Chairman and Chief Executive Officer Terry Duffy. "Our third-quarter average daily volume surpassed 20 million contracts per day, driven by strong, double-digit growth in interest rates, equity index and metals products, as well as robust trading volumes outside of the U.S. Likewise, our options products and newer, innovative contracts, like SOFR and Micro E-mini Equity futures, contributed to substantial volume growth during the quarter."

Third-quarter 2019 average daily volume (ADV) grew 30% from third-quarter 2018 to 20.2 million contracts per day. CME Group's ADV transacted outside the U.S. reached 5.3 million contracts during the quarter, up 40% compared with third-quarter 2018, including 34% growth in Europe, 61% growth in Asia and 87% growth in greater Latin America.


1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation materials.

- more -





The following information was filed by Cme Group Inc. (CME) on Wednesday, October 30, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Cme Group Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cme Group Inc..

Continue

Assess how Cme Group Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cme Group Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Expense
Debt
Product
Income
Earnings
Shares
Geography
Dividend
Other
Inside Cme Group Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Consolidated Statements Of Shareholders' Equity
Consolidated Statements Of Shareholders' Equity (Parenthetical)
Accounting Policies (Details)
Accounting Policies (Notes)
Accumulated Other Comprehensive Income (Details)
Accumulated Other Comprehensive Income (Notes)
Accumulated Other Comprehensive Income (Tables)
Basis Of Presentation
Contingencies
Debt
Debt (Schedule Of Maturities Of Long-Term Debt) (Details)
Debt (Schedule Of Short-Term And Long-Term Debt) (Details)
Debt (Tables)
Debt Narrative (Details) (Details)
Debt Short Term Debt (Details)
Earnings Per Share
Earnings Per Share (Narrative) (Details)
Earnings Per Share (Net Income Attributable To Cme Group) (Details)
Earnings Per Share (Tables)
Fair Value Measurements
Fair Value Measurements (Estimated Fair Values Of Long-Term Debt) (Details)
Fair Value Measurements (Financial Instruments Measured At Fair Value On A Recurring Basis) (Details)
Fair Value Measurements (Narrative) (Details)
Fair Value Measurements (Tables)
Fair Value Measurements Reconciliation Of Level 3 Liabilities (Details)
Guarantees
Guarantees (Details)
Intangible Assets And Goodwill
Intangible Assets And Goodwill (Components Of Intangible Assets) (Details)
Intangible Assets And Goodwill (Future Estimated Amortization Expense) (Details)
Intangible Assets And Goodwill (Narrative) (Details)
Intangible Assets And Goodwill (Tables)
Intangible Assets And Goodwill Goodwill (Details)
Leases (Details)
Leases (Notes)
Leases (Tables)
Leases Capital Leases, Future Minimum Payments Due (Details)
Leases Lease Costs (Details)
Leases Leases (Details)
Leases Operating Leases Future Minimum Payments (Details)
Leases Supplemental Balance Sheet Information-Leases (Details)
Leases Supplemental Cash Flow Information-Leases (Details)
Performance Bonds And Guaranty Fund Contributions (Details)
Performance Bonds And Guaranty Fund Contributions (Notes)
Revenue Recognition (Details)
Revenue Recognition (Notes)
Revenue Recognition (Tables)
Revenue Recognition Disaggregation Of Revenue (Details)
Subsequent Events (Notes)

Material Contracts, Statements, Certifications & more

Cme Group Inc. provided additional information to their SEC Filing as exhibits

Ticker: CME
CIK: 1156375
Form Type: 10-Q Quarterly Report
Accession Number: 0001156375-19-000114
Submitted to the SEC: Wed Nov 06 2019 12:30:29 PM EST
Accepted by the SEC: Wed Nov 06 2019
Period: Monday, September 30, 2019
Industry: Security And Commodity Brokers Dealers Exchanges And Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cme/0001156375-19-000114.htm